Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Change in Inventory (2016 - 2025)

Haemonetics has reported Change in Inventory over the past 17 years, most recently at -$13.8 million for Q4 2025.

  • Quarterly results put Change in Inventory at -$13.8 million for Q4 2025, down 179.86% from a year ago — trailing twelve months through Dec 2025 was -$38.5 million (down 146.05% YoY), and the annual figure for FY2025 was $64.7 million, up 7.73%.
  • Change in Inventory for Q4 2025 was -$13.8 million at Haemonetics, up from -$21.8 million in the prior quarter.
  • Over the last five years, Change in Inventory for HAE hit a ceiling of $36.2 million in Q2 2024 and a floor of -$21.8 million in Q3 2025.
  • Median Change in Inventory over the past 5 years was $1.4 million (2022), compared with a mean of $1.8 million.
  • Biggest five-year swings in Change in Inventory: tumbled 574.14% in 2022 and later surged 756.92% in 2024.
  • Haemonetics' Change in Inventory stood at -$3.1 million in 2021, then surged by 148.21% to $1.5 million in 2022, then surged by 578.37% to $10.1 million in 2023, then surged by 72.17% to $17.3 million in 2024, then crashed by 179.86% to -$13.8 million in 2025.
  • The last three reported values for Change in Inventory were -$13.8 million (Q4 2025), -$21.8 million (Q3 2025), and -$3.3 million (Q2 2025) per Business Quant data.